A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial.
about
An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targetsReview of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders.Tumor necrosis factor inhibitors in psoriatic arthritis.The safety of ustekinumab for the treatment of psoriatic arthritis.Apremilast: A Review in Psoriasis and Psoriatic Arthritis.Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis.PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue.Safety and Efficacy of Apremilast Through 104 Weeks in Patients With Moderate to Severe Psoriasis Who Continued on Apremilast or Switched From Etanercept Treatment: Findings From the LIBERATE Study.Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence.Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis.Management of Common Side Effects of Apremilast.Apremilast for the treatment of active psoriatic arthritis: a single-centre real-life experience.Advances in treating psoriasis in the elderly with small molecule inhibitors.Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE).Consensus on the management of patients with psoriatic arthritis in a dermatology setting.Baseline patient characteristics associated with response to biologic therapy in patients with psoriatic arthritis enrolled in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial.Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies.The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future
P2860
Q28077367-18C71077-7414-4382-9E85-DDF4B0AD7F90Q30399745-A9AA59E3-D968-41DC-8E4E-F4DABD28F982Q38685543-6C4CB5F1-AFDB-450F-95FE-65DEE40249EFQ38820480-4751BADF-1C98-4E22-9F0F-371BB08FE124Q39141679-550B4408-3168-4C2B-A634-027033BD6125Q39361316-625963C2-BCD9-4B7F-BE3E-B9DB0BC7F29CQ39375417-757CB69E-B5FC-4C73-980B-3774C32880CFQ45983415-0461BC34-AA39-44C1-A443-D72C09CFA84BQ47114261-BD183A88-F8A5-4CA4-9CEB-E289E5865CD9Q47236145-8969973B-8C24-447A-BD15-153D6754FCB8Q49382144-35609976-8627-4D3F-813A-797EE0904095Q49615779-E78C014B-7A7E-4C34-80BA-D6AE3899D05FQ49679446-D0A81421-B154-4589-A4D2-6AD2ABD62CD8Q49990438-63749B12-BC87-4E6B-A2E2-DC9AE290C65FQ50002313-3845A742-DB5D-4295-BC53-08156B52C883Q55117680-54E62039-F053-48D7-ACE0-65ABB4786544Q55316418-A8692EA7-B50E-480D-B133-41B041C2D857Q55690278-4E9048BB-3B77-47D3-907A-7E22A9B7B4C2Q58567074-819D3233-6682-4CEE-BA4D-FB7C8EABC721
P2860
A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Phase III, Randomized, Contr ...... Results of the PALACE 2 Trial.
@en
type
label
A Phase III, Randomized, Contr ...... Results of the PALACE 2 Trial.
@en
prefLabel
A Phase III, Randomized, Contr ...... Results of the PALACE 2 Trial.
@en
P2093
P356
P1476
A Phase III, Randomized, Contr ...... Results of the PALACE 2 Trial.
@en
P2093
Airi Poder
ChiaChi Hu
Eugen Feist
Filip Van den Bosch
Gary E Myerson
Helena Marzo-Ortega
Kamal Shah
Maurizio Cutolo
Randall M Stevens
Roy M Fleischmann
P304
P356
10.3899/JRHEUM.151376
P407
P577
2016-07-15T00:00:00Z